(Q42754357)

6 November 2017

NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice (English)

1 reference

6 November 2017

Gabriel Nowak

4

0 references

Andrzej Pilc

series ordinal

3

object named as

Andrzej Pilc

1 reference

6 November 2017

2

Ewa Poleszak

1 reference

PubMed ID

21273676

6 November 2017

Lucyna Pomierny-Chamioło

series ordinal

1

object named as

Lucyna Pomierny-Chamioło

1 reference

6 November 2017

1 November 2010

1 reference

6 November 2017

Pharmacological Reports

1 reference

6 November 2017

62

1 reference

6 November 2017

6

1 reference

6 November 2017

1186-1190

1 reference

AMPA receptors in the therapeutic management of depression

6 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Endogenous homer proteins regulate metabotropic glutamate receptor signaling in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Mood disorders: regulation by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

The NMDA receptor as a therapeutic target in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Glutamate-based antidepressants: 20 years on.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970381-9

7 January 2021

10.1016/S1734-1140(10)70381-9

Identifiers

DOI

1 reference

6 November 2017

1 reference

PubMed ID

21273676